⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL852575 | 0.98 | — | — | |
| SCHEMBL369955 | 0.90 | — | — | |
| SCHEMBL3842505 | 0.65 | — | — | |
| SCHEMBL16862885 | 0.64 | — | — | |
| SCHEMBL20392971 | 0.63 | — | — | |
| SCHEMBL16862858 | 0.62 | — | — | |
| SCHEMBL3201221 | 0.60 | — | — | |
| SCHEMBL3943898 | 0.57 | — | — | |
| SCHEMBL28255429 | 0.57 | — | — | |
| SCHEMBL14246967 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608793-A1 | SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE | Chevron Phillips Chemical Company LP (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20250034061-A1 | SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-01-30 | — | — | US | disclosed |
| US-12151993-B2 | Selective 1-hexene/1-octene production with 1-decene | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-11-26 | — | — | US | disclosed |
| EP-4399195-A1 | SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE | Chevron Phillips Chemical Company LP (US) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024091928-A1 | SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-05-02 | — | — | WO | disclosed |
| US-20230101033-A1 | SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2023-03-30 | — | — | US | disclosed |
| WO-2023038848-A1 | SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2023-03-16 | — | — | WO | disclosed |
| US-11498889-B1 | Selective 1-hexene/1-octene production with 1-decene | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2022-11-15 | — | — | US | disclosed |
| EP-3922622-A1 | METHOD OF INCREASING ALPHA-OLEFIN CONTENT | LiquidPower Specialty Products Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| US-11186530-B2 | Branched C18 olefins produced by metathesis of branched C10 olefins | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2021-11-30 | — | — | US | disclosed |
| US-8765984-B2 | Methods and systems for making thiol compounds from terminal olefinic compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-07-01 | — | — | US | disclosed |
| US-20120232297-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-09-13 | — | — | US | disclosed |
| WO-2009132010-A1 | METHODS AND SYSTEMS FOR MAKING THIOL COMPOUNDS FROM TERMINAL OLEFINIC COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-29 | — | — | WO | disclosed |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-22 | — | — | US | disclosed |
| US-20090043140-A1 | Narrow cut waxes and method of making | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2009-02-12 | — | — | US | disclosed |
| US-6673774-B2 | CLARITHROMYCIN MACROLIDES HAVING ENHANCED ACTIVITY TOWARDS GRAM-NEGATIVE BACTERIA AND MACROLIDE RESISTANT GRAM-POSITIVE BACTERIA; ACTIVE AGAINST MLSB-RESISTANT STRAINS (MLSB=MACROLIDES-LINCOSAMIDES-TYPE B STREPTOGRAMINES) | ENANTA PHARMACEUTICALS, INC. | 2004-01-06 | — | — | US | disclosed |
| US-6670331-B2 | Clarithromycin macrolides having enhanced activity towards gram-negative bacteria and macrolide resistant gram-positive bacteria; active against MLSB-resistant strains (MLSB=Macrolides-Lincosamides-type B Streptogramines) | ENANTA PHARMACEUTICALS, INC. | 2003-12-30 | — | — | US | disclosed |
| US-20030114396-A1 | 11-O-substituted macrolides and their descladinose derivatives | ENANTA PHARMACEUTICALS, INC. | 2003-06-19 | — | — | US | disclosed |
| US-20030114395-A1 | Novel 11-O-substituted ketolide derivatives | ENANTA PHARMACEUTICALS, INC. | 2003-06-19 | — | — | US | disclosed |
| WO-2003047601-A1 | NOVEL 11-O-SUBSTITUTED KETOLIDE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2003-06-12 | — | — | WO | disclosed |